BIG
ABBV icon

Brookwood Investment Group’s AbbVie ABBV Stock Holding History

Brookwood Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Buy
8,092
+5,346
+195% +$1.15M 0.23% 94
2026
Q1 		$597K Sell
2,746
-3,426
-56% -$760K 0.07% 253
2025
Q4 		$1.41M Buy
6,172
+596
+11% +$136K 0.17% 120
2025
Q3 		$1.29M Buy
5,576
+3,339
+149% +$680K 0.17% 113
2025
Q2 		$415K Sell
2,237
-1,209
-35% -$225K 0.07% 272
2025
Q1 		$722K Buy
+3,446
New +$670K 0.12% 165

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Brookwood Investment Group's ABBV Position: Q2 2026 in Review

Brookwood Investment Group increased its AbbVie (ABBV) stake by 195% in Q2 2026, buying an estimated $1.15M and bringing the position to 8,092 shares worth $2.04M. The position accounts for 0.23% of the portfolio, ranked #94.

Brookwood Investment Group first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Brookwood Investment Group held 8,092 shares of AbbVie worth $2.04M as of Q2 2026.
  • Brookwood Investment Group bought 5,346 AbbVie shares in Q2 2026, an estimated $1.15M.
  • AbbVie made up 0.23% of Brookwood Investment Group's portfolio in Q2 2026, its #94 holding.
  • Brookwood Investment Group first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brookwood Investment Group's 13F filing for Q2 2026, filed 23 Jul 2026.